Radar Telegram alerts Open Radar

The French company Sanofi is examining the possibility of acquiring the American biopharmaceutical company Insmed with a market value of approximately 26.6 billion dollars, reports Bloomberg. During the last 12 months, Insmed's share fell by about 40%. The deal may become the largest in the sector in a few years, but the parties are still negotiating and a decision has not yet been made.

תרגם לעברית

Кролик с Неглинной · · Source

🇺🇸 USA · Map

The French company Sanofi is examining the possibility of acquiring the American biopharmaceutical company Insmed with a market value of approximately 26.6 billion dollars, reports Bloomberg. During the last 12 months, Insmed's share fell by about 40%. The deal may become the largest in the sector in a few years, but the parties are still negotiating and a decision has not yet been made.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram